Aim To compare in vivo confocal microscopy (IVCM) with the histopathological examination of tissue and cellular changes in normal and diseased conjunctiva.
Methods Participants underwent clinical examination and IVCM of the tarsal conjunctiva. A biopsy of the upper tarsal conjunctiva was collected and stained with tinctorial stains and by immunohistochemical staining for CD45 and CD83. Connective tissue scarring, inflammatory cell density and the presence of dendritiform cells were quantitatively assessed in a masked manner by both IVCM and histological assessments for comparative analysis.
Results Thirty-four participants with severe trachomatous conjunctival scarring and 33 participants with healthy conjunctiva were recruited. The IVCM connective tissue scarring score was strongly associated with the histological grading of scarring (p<0.001). There was limited evidence of an association between the IVCM inflammatory cell infiltrate and the histological inflammatory cell grade (p=0.05). We did not find any evidence to support the hypothesis that dendritiform cells seen with IVCM are mature, conventional dendritic cells.
Conclusions The results show that IVCM can be used to robustly quantitate connective tissue scarring and also has a role in measuring the inflammatory cell infiltrate. The discordance between IVCM dendritiform cells and immunohistochemical dendritic cells may be a result of study limitations or may be because these dendritiform structures represent another cell type, such as fibroblasts, rather than dendritic cells.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Statistics from Altmetric.com
In vivo confocal microscopy (IVCM) provides high-resolution images of living tissues in a non-invasive manner. It relies on the optical principle of confocality of the illumination and observation systems, that is, the two systems are focused on the same focal points.1 Light outside of the focal plane is highly suppressed, thereby markedly increasing the resolution. This is in contrast with light biomicroscopy, for example, with a slit lamp, where there is a large amount of scattered light that limits the maximum resolution which can be attained. The confocal field of view is very small and so the microscope rapidly scans the focal point across the tissue and reconstructs an image. The image obtained is parallel to the surface being examined.
IVCM is used in several medical disciplines, including dermatology and gastroenterology, where it has been used to examine for malignant changes.2 ,3 In ophthalmology, its uses include the diagnosis and monitoring of microbial keratitis, where it may help to identify acanthamoeba cysts and filamentary fungi; assessment of potentially malignant lesions; and examination of the ocular surface after glaucoma and other forms of surgery.4
Trachoma is a chronic, scarring keratoconjunctivitis initiated by recurrent infection with Chlamydia trachomatis in childhood. The scarring complications of the disease, usually seen in adulthood, include tarsal conjunctival scarring, trichiasis and corneal opacity. We have previously used IVCM to quantify both inflammatory and scarring changes in the tarsal conjunctiva in cicatricial trachoma.5 ,6 However, interpreting IVCM images can be challenging and this is especially true for IVCM of the conjunctiva, underlying tarsal/bulbar tissue and lid margin. These contain many different structures and cell types, including goblet cells, Meibomian glands, lymphoid tissue and pseudoglands of Henle.
To validate the interpretation of IVCM images of the tarsal conjunctiva, including those from our previous studies on trachomatous scarring, we systematically compared IVCM with histological/immunohistochemical examination of the tarsal conjunctival surface. Participants with trachomatous conjunctival scarring (many of whom also had marked inflammation) and participants with healthy conjunctiva were recruited. We examined the hypotheses that the IVCM scarring score and inflammatory cell count would correspond to the grading of histological parameters, and that IVCM dendritiform cells (DFC) would be associated with the immunohistological evidence of dendritic cells (DC). Previously, there have been some attempts to compare IVCM and histological findings, but these are limited to qualitative comparisons and have employed impression cytology specimens, which do not sample subepithelial tissue.7 ,8
Materials and methods
This study adhered to the tenets of the Declaration of Helsinki. It was approved by the Tanzanian National Institute of Medical Research Ethics Committee, the Kilimanjaro Christian Medical Centre Ethics Committee and the London School of Hygiene and Tropical Medicine Ethics Committee. The study was explained to the potential study cases, and written, informed consent was obtained before enrolment. Thirty-four individuals with trachomatous trichiasis were recruited from those undergoing trichiasis surgery in the Kilimanjaro region. Thirty-three comparison participants with healthy tarsal conjunctiva were recruited from patients undergoing cataract or retinal detachment surgery at Kilimanjaro Christian Medical Centre.
All individuals were examined by an ophthalmologist using ×2.5 loupes and a bright torch. The 1981 WHO (FPC) trachoma grading system was used to grade conjunctival follicles and papillae, entropion, trichiasis and corneal opacity.9 A more detailed grading system was used for conjunctival scarring as previously described.6 ,10
Confocal microscopy assessment
IVCM examination of the upper tarsal conjunctiva was performed using the Heidelberg Retina Tomograph 3 (HRT3) in combination with the Rostock Corneal Module (Heidelberg Engineering GmbH, Dossenheim, Germany). Image grading protocols, as previously described, were used to grade features, including the inflammatory cell density, the presence of DFC and subepithelial connective tissue scarring. These protocols are shown shown in online supplementary figures S1 and S2.5 ,6 ,11 An analysis of IVCM parameters in relation to the degree of clinically apparent conjunctival scarring in this group has been previously presented.6
Biopsy samples and staining
The eyelid was anaesthetised with an injection of 2% lignocaine (Vital Healthcare, India) and the eye cleaned with 5% povidone iodine. A biopsy sample was taken using a 3 mm trephine from the tarsal conjunctiva, 2 mm from the lid margin, at the junction of the medial two-third and lateral one-third of the everted lid. All samples were taken from the eye in which the IVCM had been performed. Samples were immediately placed in 10% neutral buffered formalin and subsequently embedded in paraffin wax. Sections, 4 µm thick, were cut perpendicular to the conjunctival surface and stained with H&E, elastin/Van Gieson (EVG) and stained by immunohistochemistry for CD45 as a marker of nucleated haematopoietic cells (mouse monoclonal antibody, Dako, UK, Clones 2B11+PD7/26, 1 : 800) and for CD83 as a marker of mature DCs (mouse monoclonal antibody, Abd Serotec, UK, Clone HB1e, 1 : 75). Prior to immunohistochemical staining, sections were dewaxed and pressure cooked for 4 min in deionised water with antigen retrieval solution (Vector Lab, UK). After incubation at room temperature for 30 min with the primary antibody, sections were incubated with a biotinylated secondary antibody, followed by streptavadin-conjugated horseradish peroxidase (Dako, UK), and finally 3,3′-diaminobenzidine (Dako, UK) was used as the chromogen. Endogenous peroxidase was inhibited using Real Endogenous Peroxidase Block (Dako, UK). The slides were counterstained with Harris haematoxylin. All immunostaining procedures were performed using the Dako autostainer (Dako, UK). Positive control samples were provided by human tonsil sections, and omission of primary antibody controls were used throughout. This study is part of a wider survey of the immunohistochemistry of these cases, and in this regard, other components of the study provide an important source of ‘irrelevant’ antibody controls of non-specific primary antibody staining.
Microscopic examination of biopsy samples
Grading was performed by ocular pathologists who were masked to the clinical and IVCM findings. The grading was performed on the subepithelial tissue (lamina propria and stroma unless stated otherwise) using the parameters described below and illustrated in figure 1. These were chosen to enable comparison with the IVCM scarring score, inflammatory infiltrate and presence of DFC.
The degree of scarring was assessed using cross-polarised light for both the subepithelial conjunctival stroma and the tarsus. Initial comparison of the examination of picrosirius red and other tinctorial stains under cross-polarised light showed that the organisation of collagen bundles was apparent with a variety of staining methods. For assessment purposes we used EVG-stained preparations as these were available for all the samples, and we were able to identify all critical features of interest. In healthy subepithelial tissue, short connective tissue fibres running parallel to the surface in an ordered manner could be seen. In healthy tarsus, long thick bundles of collagen could be seen passing between the Meibomian glands, perpendicular to the surface, which terminated in shorter fibres running parallel to the surface, giving rise to a ‘T’ appearance. Tissue appearing healthy was graded as 0, and grades 1–3 used for progressive disorder of the normal appearance, figure 1A,B.
The inflammatory cell density was assessed using the H&E stained slides using an ordinal scale: 0=scattered cells; 1=few cells; 2=moderate number of cells; 3=abundant/confluent cells, figure 1C.
Cellular staining with the CD83 antibody was graded as an indicator of DC presence using an ordinal scale: 0=no/very few cells; 1=occasional cells; 2=moderate cells; 3=abundant/confluent cells, figure 1D. To further characterise the presence of DC we counted the number CD45 cells with dendritic morphology, where the dendritic processes ≥ twice the width of the nucleus (in order to minimise the inclusion of CD45 cells which are not DC), figure 1E. The field with the greatest density of cells using ×400 magnification was used for counting. Cells were counted in the epithelium and subepithelial stroma.
Data were entered into Access 2007 (Microsoft) and analysed using STATA V.11.0 (StataCorp LP, Texas, USA). Median values are presented, as much of the data was non-normally distributed. The Kruskal–Wallis test (with a correction for ties) was used to compare the respective scarring and inflammatory cell measurements ascertained by IVCM and histology. A non-parametric test for trend was used to look at the IVCM scarring score by the histological tarsal connective tissue scarring grade. Fisher's exact tests were used to determine the strength of association between IVCM DFC and immunohistochemical CD83 staining. The Wilcoxon rank-sum test was used to test for a difference in the number of CD45 cells with a dendritic morphology on immunohistochemistry according to the presence of IVCM DFC.
Study participants, IVCM and histopathological findings
Demographic, IVCM and histopathological characteristics of the participants are shown in table 1. Approximately half the participants were female, median age was 69 years (range 35–91 years), and the most common ethnic group was Maasai (41.8%) followed by Chagga (26.9%). Demographic, clinical and IVCM characteristics according to the presence of trachomatous scarring have been previously presented.6 The IVCM connective tissue analysis tended to show either little scarring or advanced scarring, consistent with participants being either controls with no scarring, or cases with severe clinical scarring. DFC, defined by IVCM, were present in almost one-third (31.5%) of the participants, and almost all of these had clinically visible scarring and inflammation.6 The immunohistological grading tended to be predominantly mild-moderate for all the parameters graded, although there was a range of grades present for each parameter.
Comparison of histological and IVCM connective tissue scarring assessments
The IVCM connective tissue scarring score was associated with histological subepithelial stromal (p=0.0008) and tarsal connective (p=0.002) tissue scarring grades (table 2). Any histological scarring in the subepithelial tissue was associated with increased IVCM scarring scores compared with no scarring. The IVCM scarring score showed a progressive increase with tarsal histological scarring grade (p-trend<0.001; see online supplementary figure S3).
Comparison of histological and IVCM inflammatory cell density assessments
There was limited evidence of an association between IVCM inflammatory cell density and histological inflammatory cell grade on H&E staining (p=0.05; table 3).
In this study, we found that the IVCM connective tissue scarring score was strongly associated with the histological assessment of scarring in the tarsal area. The histological quantification of scarring has itself not been well defined, particularly in the tarsal conjunctival surface. We developed a novel system for grading the amount of scarring present, using polarised light to directly visualise connective tissue fibres. Previous descriptions of conjunctival scarring in other diseases using IVCM have been very limited.12 ,13
The presence of small, round, hyper-reflective bodies has been widely reported in IVCM studies of the conjunctival surface, and these are generally accepted as representing the nuclei of inflammatory cells.14–16 We found limited evidence of an association between this apparent IVCM cell infiltrate and inflammatory cells seen histologically. Leucocytes are the most likely explanation for the cell type responsible for these hyper-reflective bodies seen on IVCM with few plausible alternative explanations. Previous studies have found a similar IVCM appearance to be associated with clinical inflammation in vernal keratoconjunctivitis, and to show a rapid increase in rabbit conjunctiva after the injection of lipopolysaccharide.15 ,17 A stronger association may have been found between the IVCM and histological inflammatory cell infiltrates in this study if the IVCM had been performed in the precise area where the biopsy was taken from. Unfortunately, it is not possible to ensure that the site of the biopsy and the IVCM image are at exactly the same point, as the image area is small (400×400 µm), and the confocal microscope cap is relatively bulky, making it difficult to identify the precise location of the scan. Instead, mean values derived from multiple scans from all over the tarsal surface were used. It is possible that the particular biopsy site may not have been representative of the rest of the tarsal conjunctiva.
We found no association between the presence of IVCM DFC and the histological identification of DC. This may be a result of study limitations. To maximise the number of histological sections available, they were cut perpendicular to the conjunctival surface. This may limit the detection of DC, as the dendritic processes appear to spread out parallel to the surface, and so may be more easily identified by IVCM, where the image obtained is parallel to the surface. IVCM images were obtained for analysis from multiple points across the tarsal conjunctiva, with summary values for scarring, and other indices being averaged from these. These were compared with a single biopsy specimen, and comparison of the two techniques may be limited. It was not possible to be certain about scanning and sampling the same site, as discussed above, again limiting the comparisons made. While the IVCM and histological grading were performed in a masked manner, it was still possible for the IVCM scan or histological tissue section itself to provide clues to the clinical status of the patient with the potential to unmask the observers leading to bias. However, every attempt was made to perform the grading as objectively as possible using clearly specified criteria.
DC immunophenotyping is complex and requires a combination of staining intensity coupled with positive and negative markers in order to confidently identify different DC types.18 ,19 We had insufficient tissue to exhaustively characterise this cell population and selected markers which we expected would best indicate a number of cell types including DC. The IVCM grading identified DFC with well-developed dendritic processes, suggesting mature DC which would usually stain with CD83.20 ,21 The use of cellular CD45 staining and dendritic morphology should also have identified mature DC. However, to be able to determine with greater certainty whether the IVCM DFCs represent DCs would require a number of further stains.
An alternative explanation for the apparent discordance between the IVCM and histological findings is that the DFC seen on IVCM are not actually DCs. There has been no previous work on the histological characterisation of these DFCs. One possibility, suggested by other studies, is that these dendritiform structures are fibroblasts, which can have marked dendritic extensions.22 ,23 IVCM studies have shown similar DFCs to be increased in microbial infection, vernal keratoconjunctivitis, contact lens wear, immune-mediated inflammation and pterygium.17 ,24 ,25 Many of these conditions are associated with scarring, where fibroblasts would be expected to be present. The cornea contains numerous keratocytes, and these can transform into activated corneal fibroblasts in response to injury.26 ,27 The comprehensive identification of these conjunctival DFCs requires further study.
We chose to use an ordinal scale for the immunohistological grading of inflammatory cells and cellular CD83 staining, with the observer masked to the clinical status. Alternative forms of analysis include cell counts on representative fields. However, this is open to bias unless the fields selected are chosen at random, which itself can present difficulties if the infiltrate is not evenly distributed within the tissue. Additionally, the use of representative fields restricts the amount of tissue used for the assessment.
This is the first time that IVCM analysis has been objectively and quantitatively compared with immunohistological findings in the ocular surface. Masked observers and defined grading systems on a large number of participants were used, thereby allowing significance testing to be performed. These findings are likely to have relevance for other scarring diseases of the ocular surface, such as mucous membrane pemphigoid.
We would like to acknowledge the help of Heidi Barnes and Caroline Thaung at the Institute of Ophthalmology with processing the biopsy samples and with using the microscope camera. We would also like to thank Anthony Hall and the theatre staff at the Eye Department of the Kilimanjaro Christian Medical Centre for their help with recruiting participants.
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online figures
Contributors Conception and design: VHH, MJH, DCWM, RLB & MJB. Acquisition of data: VHH, PM & WM. Interpretation of IVCM images: VHH & MJB. Histopathological processing and analysis of slides: MJH, IAC, JP & PL. Statistical analysis: VHH & HW. Drafting and revising the article: VHH, MJH, IAC, HAW, WM, DCWM RLB, MJB & PL.
Funding Wellcome Trust & British Council for Prevention of Blindness.
Competing interests None.
Ethics approval London School of Hygiene and Tropical Medicine; Tanzanian National Institute of Medical Research Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.